Clinical management of oxaliplatin-associated neurotoxicity

A Grothey - Clinical colorectal cancer, 2005 - Elsevier
In recent years, oxaliplatin-based chemotherapy protocols, particularly oxaliplatin in
combination with infusional 5-fluorouracil/leucovorin (FOLFOX or FUFOX), have emerged as …

From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates

J Walling - Investigational new drugs, 2006 - Springer
This review will discuss the key preclinical and clinical features of antifolates, from
methotrexate (MTX) to pemetrexed and beyond. Despite 50 years of study, definition of the …

雷替曲塞或氟尿嘧啶/亚叶酸钙联合奥沙利铂治疗局部晚期或复发转移性结直肠癌的随机对照多中心Ⅲ 期临床试验

王佳蕾, 李进, 秦叔逵, 程颖, 张清媛… - 临床肿瘤学 …, 2012 - manu65.magtech.com.cn
目的前瞻性比较雷替曲塞或氟尿嘧啶/亚叶酸钙联合奥沙利铂治疗局部晚期或复发转移性结直肠
癌的有效性和安全性. 方法经病理组织学或细胞学确诊的局部晚期或复发转移性的结直肠癌患者 …

Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy

T Lecomte, B Landi, P Beaune, P Laurent-Puig… - Clinical Cancer …, 2006 - AACR
Abstract Purpose: Glutathione S-transferases (GST) are xenobiotic metabolizing enzymes
involved in the detoxification of a variety of chemotherapeutic drugs, including platinum …

Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer

GD Leonard, MA Wright, MG Quinn, S Fioravanti… - BMC cancer, 2005 - Springer
Background New chemotherapy regimens for patients with colorectal cancer have improved
survival, but at the cost of clinical toxicity. Oxaliplatin, an agent used in first-line therapy for …

[HTML][HTML] Fatigue in cancer patients receiving chemotherapy: an analysis of published studies

A Iop, AM Manfredi, S Bonura - Annals of oncology, 2004 - Elsevier
Fatigue is a subjective experience that affects everybody. In healthy individuals, it can be
considered a physiological response to physical or psychological stress. In people with …

Antifolate inhibitors of thymidylate synthase as anticancer drugs

A Jarmula - Mini reviews in medicinal chemistry, 2010 - ingentaconnect.com
Inhibitors of thymidylate synthase (TS) play an essential role in the pharmacological
management of several tumors. Two antifolates, Raltitrexed and Pemetrexed, are licensed …

Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer

D Simpson, C Dunn, M Curran, KL Goa - Drugs, 2003 - Springer
Oxaliplatin (Eloxatin™) is the only platinum compound to show clinical activity in colorectal
cancer. The efficacy of a combination of oxaliplatin with various schedules of fluorouracil (5 …

Raltitrexed-based chemotherapy for advanced colorectal cancer

Y Liu, W Wu, W Hong, X Sun, J Wu, Q Huang - Clinics and research in …, 2014 - Elsevier
Aims To evaluate the efficiency and safety profile of raltitrexed-based chemotherapy in the
treatment of advanced colorectal cancer. Methods An electronic search was undertaken to …

Oncological treatment-related fatigue in oncogeriatrics: a scoping review

L André, G Antherieu, A Boinet, J Bret, T Gilbert… - Cancers, 2022 - mdpi.com
Simple Summary Fatigue in older patients has multiple etiologies, as this symptom may be
cancer-related, treatment-related, age-related, or part of frailty syndrome. Physicians need to …